Department of Medicine and Surgery, University of Parma, Italy.
Department of Health Sciences, University of Genoa, Italy.
J Prev Med Hyg. 2020 Jul 4;61(2):E143-E147. doi: 10.15167/2421-4248/jpmh2020.61.2.1402. eCollection 2020 Jun.
This overview shows how tuberculosis has represented and still represents a continuous challenge for Medicine. Starting from the dawn of medicine, when tuberculosis was called "phthisis" by Hippocrates, passing through the discovery of the tubercles and the creation of the word "tuberculosis", following the application of the anatomo-clinical method, until the discovery of a microscopic enemy: Mycobacterium tuberculosis. The progressive discovery of the pathological basis of tuberculosis has allowed to devise important therapeutic strategies in Pre-Antibiotic and Post-Antibiotic Era. In particular, "antibiotic therapy" had to be the end of the challenge between man and tuberculosis. However it was only an illusion. Despite progress in care and prevention, tuberculosis remains one of the world's leading causes of ill-health and the first cause of death from infectious disease. Nowadays, the drug resistance, individuals with immune deficiencies, the ageing and globalization are just some of the causes responsible for the increasing of the challenge between man and tuberculosis.
这篇综述展示了结核病如何以及仍然是医学的持续挑战。从医学的黎明开始,当时结核病被希波克拉底称为“痨病”,经历了结核结节的发现和“结核病”一词的创造,接着是解剖临床方法的应用,直到发现了一种微观敌人:结核分枝杆菌。结核病病理学基础的逐步发现使人们能够在抗生素前和抗生素后时代制定重要的治疗策略。特别是,“抗生素治疗”必须是人类与结核病之间挑战的终点。然而,这只是一种幻觉。尽管在护理和预防方面取得了进展,但结核病仍然是世界上导致健康不良的主要原因之一,也是传染病死亡的首要原因。如今,耐药性、免疫功能低下者、老龄化和全球化只是导致人类与结核病之间挑战不断增加的部分原因。